Private Equity
'Despite the slowdown in PE-backed healthcare services transactions in 2023, in part due to the regulatory environment, there is still value to be unlocked.'
3 min read · 22 July 2024
Masco provides engineered products and services for the pharma and biotech industries.
2 min read · 22 July 2024
Famar is a pharmaceutical CDMO.
2 min read · 22 July 2024
The firm agreed to buy a majority stake in FairJourney, valued at around €900m, in early July.
3 min read · 22 July 2024
Dechra is an international veterinary pharmaceuticals business.
1 min read · 19 July 2024
Based in Nashville, Ardent Health is a provider of healthcare in growing midsize urban communities across the country.
1 min read · 18 July 2024
OTTO LSE provides services to pharmaceutical and biotechnology production facilities and laboratories.
1 min read · 18 July 2024
Under Partners Group’s five-year hold, Confluent expanded its network from 200 to 730 clinics and did add-ons such as Motion PT Group.
2 min read · 17 July 2024
Avista and Hamilton Lane will jointly control Cosette going forward.
1 min read · 17 July 2024
Avista will retain a significant equity stake and jointly manage Cosette’s growth alongside Hamilton Lane, PE Hub has learned.
2 min read · 17 July 2024
